Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Gut uropathogen abundance is a risk factor for development of bacteriuria and urinary tract infection.

Magruder M, Sholi AN, Gong C, Zhang L, Edusei E, Huang J, Albakry S, Satlin MJ, Westblade LF, Crawford C, Dadhania DM, Lubetzky M, Taur Y, Littman E, Ling L, Burnham P, De Vlaminck I, Pamer E, Suthanthiran M, Lee JR.

Nat Commun. 2019 Dec 4;10(1):5521. doi: 10.1038/s41467-019-13467-w.

PMID:
31797927
2.

MANAGEMENT OF HYPERPARATHYROIDISM IN KIDNEY TRANSPLANTATION CANDIDATES: A NEED FOR CONSENSUS.

Golingan H, Samuels SK, Camacho P, Dadhania DM, Pedraza-Taborda FE, Randolph G, Parangi S, Bimston DN, Harrell RM.

Endocr Pract. 2019 Nov 4. doi: 10.4158/EP-2019-0392. [Epub ahead of print]

PMID:
31682519
3.

Butyrate-producing gut bacteria and viral infections in kidney transplant recipients: A pilot study.

Lee JR, Huang J, Magruder M, Zhang LT, Gong C, Sholi AN, Albakry S, Edusei E, Muthukumar T, Lubetzky M, Dadhania DM, Taur Y, Pamer EG, Suthanthiran M.

Transpl Infect Dis. 2019 Sep 22:e13180. doi: 10.1111/tid.13180. [Epub ahead of print]

PMID:
31544324
4.

Gastrointestinal pathogen colonization and the microbiome in asymptomatic kidney transplant recipients.

Westblade LF, Satlin MJ, Albakry S, Botticelli B, Robertson A, Alston T, Magruder M, Zhang LT, Edusei E, Chan K, Lubetzky M, Dadhania DM, Pamer EG, Suthanthiran M, Lee JR.

Transpl Infect Dis. 2019 Sep 10:e13167. doi: 10.1111/tid.13167. [Epub ahead of print]

PMID:
31502737
5.

Cardiovascular disease care fragmentation in kidney transplantation: a call for action.

Rangaswami J, Bangalore S, Kaplan B, Birdwell KA, Wiseman AC, McCullough PA, Dadhania DM.

Kidney Int. 2019 Sep;96(3):568-571. doi: 10.1016/j.kint.2019.04.042. Epub 2019 Jun 10. No abstract available.

PMID:
31349974
6.

Landscape of innate immune system transcriptome and acute T cell-mediated rejection of human kidney allografts.

Mueller FB, Yang H, Lubetzky M, Verma A, Lee JR, Dadhania DM, Xiang JZ, Salvatore SP, Seshan SV, Sharma VK, Elemento O, Suthanthiran M, Muthukumar T.

JCI Insight. 2019 Jul 11;4(13). pii: 128014. doi: 10.1172/jci.insight.128014. eCollection 2019 Jul 11.

7.

Cardiovascular disease in the kidney transplant recipient: epidemiology, diagnosis and management strategies.

Rangaswami J, Mathew RO, Parasuraman R, Tantisattamo E, Lubetzky M, Rao S, Yaqub MS, Birdwell KA, Bennett W, Dalal P, Kapoor R, Lerma EV, Lerman M, McCormick N, Bangalore S, McCullough PA, Dadhania DM.

Nephrol Dial Transplant. 2019 May 1;34(5):760-773. doi: 10.1093/ndt/gfz053.

PMID:
30984976
8.

Factors at de novo donor-specific antibody initial detection associated with allograft loss: a multicenter study.

Schinstock CA, Dadhania DM, Everly MJ, Smith B, Gandhi M, Farkash E, Sharma VK, Samaniego-Picota M, Stegall MD.

Transpl Int. 2019 May;32(5):502-515. doi: 10.1111/tri.13395. Epub 2019 Feb 8.

PMID:
30597643
9.

Single nucleotide variant counts computed from RNA sequencing and cellular traffic into human kidney allografts.

Thareja G, Yang H, Hayat S, Mueller FB, Lee JR, Lubetzky M, Dadhania DM, Belkadi A, Seshan SV, Suhre K, Suthanthiran M, Muthukumar T.

Am J Transplant. 2018 Oct;18(10):2429-2442. doi: 10.1111/ajt.14870. Epub 2018 May 15.

10.

Kidney allograft failure in the steroid-free immunosuppression era: A matched case-control study.

Alkadi MM, Kim J, Aull MJ, Schwartz JE, Lee JR, Watkins A, Lee JB, Dadhania DM, Seshan SV, Serur D, Kapur S, Suthanthiran M, Hartono C, Muthukumar T.

Clin Transplant. 2017 Nov;31(11). doi: 10.1111/ctr.13117.

PMID:
28921709
11.

The Value of Protocol Biopsies to Identify Patients With De Novo Donor-Specific Antibody at High Risk for Allograft Loss.

Schinstock CA, Cosio F, Cheungpasitporn W, Dadhania DM, Everly MJ, Samaniego-Picota MD, Cornell L, Stegall MD.

Am J Transplant. 2017 Jun;17(6):1574-1584. doi: 10.1111/ajt.14161. Epub 2017 Jan 25.

12.

Development and validation of a prognostic index for allograft outcome in kidney recipients with transplant glomerulopathy.

Patri P, Seshan SV, Matignon M, Desvaux D, Lee JR, Lee J, Dadhania DM, Serur D, Grimbert P, Hartono C, Muthukumar T.

Kidney Int. 2016 Feb;89(2):450-8.

13.

Urine Metabolite Profiles Predictive of Human Kidney Allograft Status.

Suhre K, Schwartz JE, Sharma VK, Chen Q, Lee JR, Muthukumar T, Dadhania DM, Ding R, Ikle DN, Bridges ND, Williams NM, Kastenm├╝ller G, Karoly ED, Mohney RP, Abecassis M, Friedewald J, Knechtle SJ, Becker YT, Samstein B, Shaked A, Gross SS, Suthanthiran M.

J Am Soc Nephrol. 2016 Feb;27(2):626-36. doi: 10.1681/ASN.2015010107. Epub 2015 Jun 5.

14.

Solid organ transplantation from hepatitis B virus-positive donors: consensus guidelines for recipient management.

Huprikar S, Danziger-Isakov L, Ahn J, Naugler S, Blumberg E, Avery RK, Koval C, Lease ED, Pillai A, Doucette KE, Levitsky J, Morris MI, Lu K, McDermott JK, Mone T, Orlowski JP, Dadhania DM, Abbott K, Horslen S, Laskin BL, Mougdil A, Venkat VL, Korenblat K, Kumar V, Grossi P, Bloom RD, Brown K, Kotton CN, Kumar D.

Am J Transplant. 2015 May;15(5):1162-72. doi: 10.1111/ajt.13187. Epub 2015 Feb 23.

15.

Allograft rejection and tubulointerstitial fibrosis in human kidney allografts: interrogation by urinary cell mRNA profiling.

Muthukumar T, Lee JR, Dadhania DM, Ding R, Sharma VK, Schwartz JE, Suthanthiran M.

Transplant Rev (Orlando). 2014 Jul;28(3):145-54. doi: 10.1016/j.trre.2014.05.003. Epub 2014 May 27. Review.

16.

Urinary cell mRNA profiles and differential diagnosis of acute kidney graft dysfunction.

Matignon M, Ding R, Dadhania DM, Mueller FB, Hartono C, Snopkowski C, Li C, Lee JR, Sjoberg D, Seshan SV, Sharma VK, Yang H, Nour B, Vickers AJ, Suthanthiran M, Muthukumar T.

J Am Soc Nephrol. 2014 Jul;25(7):1586-97. doi: 10.1681/ASN.2013080900. Epub 2014 Mar 7.

17.

Excretion of anti-angiogenic proteins in patients with chronic allograft dysfunction.

Moskowitz-Kassai E, Mackelaite L, Chen J, Patel K, Dadhania DM, Gross SS, Chander P, Delaney V, Deng L, Chen L, Cui X, Suthanthiran M, Goligorsky MS.

Nephrol Dial Transplant. 2012 Feb;27(2):494-7. doi: 10.1093/ndt/gfr638. Epub 2012 Jan 17.

18.

Pharmacodynamics of basic fibroblast growth factor: route of administration determines myocardial and systemic distribution.

Lazarous DF, Shou M, Stiber JA, Dadhania DM, Thirumurti V, Hodge E, Unger EF.

Cardiovasc Res. 1997 Oct;36(1):78-85.

PMID:
9415275

Supplemental Content

Loading ...
Support Center